InsidersTradesSigma
Discover the full directors' dealings record of Hangzhou Diagens Biotechnology Co., Ltd. - B, a publicly traded company based in Hong Kong. Shares trade on HK HK, under the oversight of HKEX. Operating in the Healthcare sector, Hangzhou Diagens Biotechnology Co., Ltd. - B has published 1 reports. Market capitalisation: €27.7bn. The latest transaction was filed on 14 April 2026 — Other. Among the most active insiders: SONG Ning. The full history is free.
FY ended December 2025 · cache
0 of 0 declarations